UBS analyst Eliana Merle reiterated a Buy rating and $25.00 price target on 89bio Inc. (NASDAQ: ETNB).The analyst comments "Survodutide ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE